Eflornithine

Edina Avdic, Pharm.D., Paul A. Pham, Pharm.D.
Eflornithine is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or .

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Eflornithine (IV): no longer commercially available in the U.S.
  • Treatment of unwanted facial hair in women (topical cream)

NON-FDA APPROVED USES

  • African trypanosomiasis (sleeping sickness):Second-stage T. b. gambiense
    • Eflornithine is not effective against T. b. rhodesiense(East African form of the diseases)
    • Drug can be obtained from CDC by contacting the Division of Parasitic Diseases and Malaria (telephone, 404-718-4745; email, parasites@cdc.gov).

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

  • Eflornithine (IV): no longer commercially available in the U.S.
  • Treatment of unwanted facial hair in women (topical cream)

NON-FDA APPROVED USES

  • African trypanosomiasis (sleeping sickness):Second-stage T. b. gambiense
    • Eflornithine is not effective against T. b. rhodesiense(East African form of the diseases)
    • Drug can be obtained from CDC by contacting the Division of Parasitic Diseases and Malaria (telephone, 404-718-4745; email, parasites@cdc.gov).

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: June 3, 2017